SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2752Is this the likely reason for TEVA being down over $3 while MNTA moved up 4.6% tIan@SI-2/8/2011
2751<i>Maybe they will say something on Wednesday to support the notion that apollyvonwog-2/8/2011
2750But with enough hedging that everyone will be able to assert that whatever tEnoxtom pope-2/7/2011
2749<i>Teva's approval is likely, no matter what some say, by mid-summer.&Cactus Quave-2/7/2011
2748Teva's approval is likely, no matter what some say, by mid-summer. That is Robohogs-2/7/2011
2747>>There is a lot of parsing and reparsing of questions like when is a lupeIRWIN JAMES FRANKEL-2/7/2011
2746There <i>is</i> a lot of parsing and reparsing of questions like whetom pope-2/5/2011
2745Not really. Too tedious. <<<Haven't you been following all the corkrw-2/4/2011
2744Thanks, tuck, you're one persistent digger!tom pope12/4/2011
2743"the issue with their Jerusalem facility is probably not relevant to Momentidos-2/4/2011
2742Haven't you been following all the convolutions at IHub? The last time a motuck32/4/2011
2741Given that the motion for expedited discovery mentions an Italian 3rd party, thutuck-2/4/2011
2740If it is Lupenox, how did Teva infringe?rkrw22/3/2011
2739Not that I'd wish them any trouble... ;) 6:45AM Teva Pharma discloses warnIan@SI-2/3/2011
2738Link to Momenta's motion for expedited discovery in their infringement suit tuck-2/3/2011
2737 * JANUARY 31, 2011, 3:46 A.M. ET Generics Companies Weigh In on Biological Ian@SI-1/31/2011
2736cs:teva FDA letter increases our confidence in generic Lovenox timing, and doemopgcw-1/30/2011
2735>>Let's assume that Teva infringed MNTA IP when determining the approptuck-1/27/2011
2734<i>Thus my odds of t-nox getting approved in 6 months are substantially loBiomaven-1/26/2011
2733Let's assume that Teva infringed MNTA IP when determining the appropriate teBiomaven-1/26/2011
2732>>For example, it's quite possible that Teva "infringed" durtuck51/26/2011
2731Thanks for your input Peter! I have wondered if the lack of partnering may be dghmm-1/26/2011
2730<i>Any value for their FOB programs/technology in general?</i> Yes,Biomaven-1/25/2011
2729Any value for their FOB programs/technology in general? If Insmed got 130 millighmm-1/25/2011
2728<i>~50M shares so ~$6ps</i> Thanks. And it's reasonable to assiBiomaven-1/25/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News